UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 447

Sortiert nach

The Worst Combination for Coronary Artery Disease Under Strong-Statin Therapy Is Chronic Kidney Disease and Diabetes　― Non-Lipid Residual Risk Assessment From the REAL-CAD Study

Circulation Journal, 2023/10/19, pp.CJ-23-0694

Nohara, Atsushi

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and “Heterozygous FH Score” from FAME Study

Journal of Atherosclerosis and Thrombosis, 2022/05/01, Vol.29(5), pp.567-570

Nohara, Atsushi

2022

Link zum Volltext

Verfügbarkeit prüfen

Rare and Deleterious Mutations in ABCG5/ABCG8 Genes Contribute to Mimicking and Worsening of Familial Hypercholesterolemia Phenotype

Circulation Journal, 2019/08/23, Vol.83(9), pp.1917-1924

2019

Link zum Volltext

Verfügbarkeit prüfen

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease

Journal of Atherosclerosis and Thrombosis, 2018/09/01, Vol.25(9), pp.783-789

2018

Link zum Volltext

Verfügbarkeit prüfen

Epicardial Adipose Tissue as a Predictor of Plaque Vulnerability in Patients With Mild Chronic Kidney Disease

Circulation Journal, 2015/12/25, Vol.80(1), pp.64-66

Nohara, Atsushi

2016

Link zum Volltext

Verfügbarkeit prüfen

Homozygous Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2021/07/01, Vol.28(7), pp.665-678

2021

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017

Journal of Atherosclerosis and Thrombosis, 2018/08/01, Vol.25(8), pp.751-770

2018

Link zum Volltext

Verfügbarkeit prüfen

Guidance for Pediatric Familial Hypercholesterolemia 2017

Journal of Atherosclerosis and Thrombosis, 2018/06/01, Vol.25(6), pp.539-553

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins　– ODYSSEY JAPAN Randomized Controlled Trial

Circulation Journal, 2016/08/25, Vol.80(9), pp.1980-1987

2016

Link zum Volltext

Verfügbarkeit prüfen

Optimal Treatment using Statins from Childhood in Heterozygous Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2016/01/06, Vol.23(1), pp.39-43

Nohara, Atsushi

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Diagnostic Criteria of Familial Hypercholesterolemia　― A Comparison of the Japan Atherosclerosis Society and Dutch Lipid Clinic Network Criteria

Circulation Journal, 2021/05/25, Vol.85(6), pp.891-897

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events

Journal of Atherosclerosis and Thrombosis, 2020/01/01, Vol.27(1), pp.38-46

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Cumulative Exposure to Low-Density Lipoprotein-Cholesterol on Cardiovascular Events in Patients With Familial Hypercholesterolemia

Circulation Journal, 2021/10/25, Vol.85(11), pp.2073-2078

2021

Link zum Volltext

Verfügbarkeit prüfen

Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene

Journal of Atherosclerosis and Thrombosis, 2022/06/01, Vol.29(6), pp.816-824

2022

Link zum Volltext

Verfügbarkeit prüfen

Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome: Genetic Insights from EXPLORE-J

Journal of Atherosclerosis and Thrombosis, 2022/08/01, Vol.29(8), pp.1201-1212

2022

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for the Management of Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2012, Vol.19(12), pp.1043-1060

2012

Link zum Volltext

Verfügbarkeit prüfen

Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J

Journal of Atherosclerosis and Thrombosis, 2021/12/01, Vol.28(12), pp.1307-1322

2021

Link zum Volltext

Verfügbarkeit prüfen

Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

Atherosclerosis, 2023-04, Vol.371, p.61-66

2023

Link zum Volltext

Verfügbarkeit prüfen

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies

Nutrients, 2018-11, Vol.10 (11), p.1789

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study

Journal of Atherosclerosis and Thrombosis, 2019/04/01, Vol.26(4), pp.368-377

2019

Link zum Volltext

Verfügbarkeit prüfen

Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease

Journal of clinical lipidology, 2018-11, Vol.12 (6), p.1436-1444

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks

Scientific reports, 2023-11, Vol.13 (1), p.19782-19782, Article 19782

2023

Link zum Volltext

Verfügbarkeit prüfen

Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors

Molecules and Cells, 2014, 37(11), , pp.777-784

2014

Link zum Volltext

Verfügbarkeit prüfen

Oral Fat Tolerance Test for Sitosterolemia and Familial Hypercholesterolemia: A Study Protocol

Journal of Atherosclerosis and Thrombosis, 2018/08/01, Vol.25(8), pp.741-746

2018

Link zum Volltext

Verfügbarkeit prüfen

Aortic Root Calcification Score as an Independent Factor for Predicting Major Adverse Cardiac Events in Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2018/07/01, Vol.25(7), pp.634-642

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 447

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(342)
Mit Volltextzugriff
(424)

Publikationsform

Sprache

Englisch
(419)
Japanisch
(147)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(274)
Life Sciences & Biomedicine
(258)
Humans
(186)
Male
(145)
Female
(112)
Middle Aged
(109)
Cardiovascular System & Cardiology
(92)
Aged
(83)
Adult
(76)
Familial Hypercholesterolemia
(64)
Peripheral Vascular Disease
(60)
Cardiac & Cardiovascular Systems
(52)
Japan
(48)
Oncology
(41)
Risk Factors
(37)
Biological And Medical Sciences
(36)
Mutation
(31)
Hyperlipoproteinemia Type Ii - Genetics
(30)
Medical Sciences
(29)
Patients
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

The Worst Combination for Coronary Artery Disease Under Strong-Statin Therapy Is Chronic Kidney Disease and Diabetes　― Non-Lipid Residual Risk Assessment From the REAL-CAD Study

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and “Heterozygous FH Score” from FAME Study

Rare and Deleterious Mutations in ABCG5/ABCG8 Genes Contribute to Mimicking and Worsening of Familial Hypercholesterolemia Phenotype

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease

Epicardial Adipose Tissue as a Predictor of Plaque Vulnerability in Patients With Mild Chronic Kidney Disease

Homozygous Familial Hypercholesterolemia

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017

Guidance for Pediatric Familial Hypercholesterolemia 2017

Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins　– ODYSSEY JAPAN Randomized Controlled Trial

Optimal Treatment using Statins from Childhood in Heterozygous Familial Hypercholesterolemia

Clinical Diagnostic Criteria of Familial Hypercholesterolemia　― A Comparison of the Japan Atherosclerosis Society and Dutch Lipid Clinic Network Criteria

Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events

Effect of Cumulative Exposure to Low-Density Lipoprotein-Cholesterol on Cardiovascular Events in Patients With Familial Hypercholesterolemia

Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene

Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome: Genetic Insights from EXPLORE-J

Guidelines for the Management of Familial Hypercholesterolemia

Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J

Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies

Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study

Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks

Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors

Oral Fat Tolerance Test for Sitosterolemia and Familial Hypercholesterolemia: A Study Protocol

Aortic Root Calcification Score as an Independent Factor for Predicting Major Adverse Cardiac Events in Familial Hypercholesterolemia

Suchergebnisse filtern